TrialInternational journal of hematology2025
Long-term safety and efficacy of fostamatinib in Japanese patients with primary immune thrombocytopenia.
Masataka Kuwana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it